The Effect of Optivite for Women on Premenstrual Tension Syndromes: Blood Chemistry and Serum Steroid Levels During the Mid-Luteal Phase

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 23(6), 667-670

Source

Abstract

Plasma and erythrocyte magnesium were measured in 105 patients with premenstrual syndrome (PMS) using a simple atomic absorption spectroscopy method. The erythrocyte magnesium concentration for the patients with PMS was significantly lower than that of a normal population. The plasma magnesium did not show this difference. The significance of this apparent cellular deficiency of magnesium is discussed.

Topics

Optivite premenstrual tension syndrome treatment, magnesium deficiency premenstrual syndrome, erythrocyte magnesium PMS women, Abraham GE premenstrual syndrome nutritional supplement, mid-luteal phase steroid levels premenstrual tension, micronutrient supplement PMS blood chemistry, cellular magnesium deficiency menstrual cycle, plasma erythrocyte magnesium atomic absorption spectroscopy, serum steroid levels luteal phase PMS, nutritional supplementation premenstrual syndrome treatment

Cite this article

Fuchs, N., Hakim, M., & Abraham, G. E. (1985). The Effect of Optivite for Women on Premenstrual Tension Syndromes: Blood Chemistry and Serum Steroid Levels During the Mid-Luteal Phase. *Annals of Clinical Biochemistry: International Journal of Laboratory Medicine*, *23*(6), 667-670.

Related articles